Diagnsticos Valuation
| DASA3 Stock | BRL 2.24 0.06 2.61% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Diagnsticos da Amrica prevailing Real Value cannot be determined due to lack of data. The current price of Diagnsticos da Amrica is R$2.24. Our model computes the value of Diagnsticos da Amrica from reviewing the firm fundamentals such as Profit Margin of (0.03) %, current valuation of 17.24 B, and Operating Margin of 0.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Diagnsticos' price fluctuation is out of control at this time. Calculation of the real value of Diagnsticos da Amrica is based on 3 months time horizon. Increasing Diagnsticos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Diagnsticos stock is determined by what a typical buyer is willing to pay for full or partial control of Diagnsticos da Amrica. Since Diagnsticos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Diagnsticos Stock. However, Diagnsticos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.24 | Real 0.0 | Hype 0.0 | Naive 2.27 |
The intrinsic value of Diagnsticos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Diagnsticos' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Diagnsticos da Amrica helps investors to forecast how Diagnsticos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diagnsticos more accurately as focusing exclusively on Diagnsticos' fundamentals will not take into account other important factors: Diagnsticos Total Value Analysis
Diagnsticos da Amrica is currently projected to have takeover price of 17.24 B with market capitalization of 5.51 B, debt of 6.97 B, and cash on hands of 832.69 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnsticos fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.24 B | 5.51 B | 6.97 B | 832.69 M |
Diagnsticos Investor Information
About 56.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Diagnsticos da Amrica recorded a loss per share of 0.31. The entity last dividend was issued on the 27th of December 2022. The firm had 4:1 split on the 2nd of February 2010. Based on the key indicators related to Diagnsticos' liquidity, profitability, solvency, and operating efficiency, Diagnsticos da Amrica is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Diagnsticos Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Diagnsticos has an asset utilization ratio of 44.81 percent. This implies that the Company is making R$0.45 for each dollar of assets. An increasing asset utilization means that Diagnsticos da Amrica is more efficient with each dollar of assets it utilizes for everyday operations.Diagnsticos Ownership Allocation
Diagnsticos holds a total of 557.11 Million outstanding shares. Diagnsticos da Amrica retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Diagnsticos Profitability Analysis
The company reported the revenue of 10.42 B. Net Loss for the year was (226.57 M) with profit before overhead, payroll, taxes, and interest of 3.12 B.About Diagnsticos Valuation
The stock valuation mechanism determines Diagnsticos' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Diagnsticos da Amrica based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Diagnsticos. We calculate exposure to Diagnsticos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Diagnsticos's related companies.Diagnsticos da Amrica S.A. provides diagnostic test services in Latin America. Diagnsticos da Amrica S.A. is a subsidiary of Cromossomo Participaes II S.A. DASA ON operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange.
8 Steps to conduct Diagnsticos' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Diagnsticos' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Diagnsticos' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Diagnsticos' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Diagnsticos' revenue streams: Identify Diagnsticos' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Diagnsticos' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Diagnsticos' growth potential: Evaluate Diagnsticos' management, business model, and growth potential.
- Determine Diagnsticos' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Diagnsticos' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Diagnsticos Stock Analysis
When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.